Agile Therapeutics financials at a glance

+ Portfolio

The revenue of Agile Therapeutics is reported as 0.01088 billion Dollars in the fiscal year 2023. The earnings were -92 Dollars per share in 2023, which was 94.03 higher than 2021. And about -0.00029 billion Dollars are reported as free cash flow in the financials of Agile Therapeutics 2023. No dividends were paid to the shareholders of the Agile Therapeutics stock NasdaqCM:AGRX in the financial year 2023.

$10.88M

Revenue

$-92.00

Earnings Per Share

37.19%

Gross Margin %

$0.00M

Free Cash Flow

Revenue

10.88

Earnings Per Share

-92.00

Gross Margin %

37.19

Free Cash Flow

0.00

Financials

Year	Year	TTM	2022	2021	2020	2019	2018	2017	2016	2015	2014
Rev.	Revenue	N/A	$10.88M	$4.10M	$0.75M	$0.00M	$0.00M	$0.00M	$0.00M	$0.00M	$0.00M
GM %	Gross Margin %	57.75%	37.19%	-,161.35%	62.35%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
OM	Operating Margin	-,113.69%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
EPS	Earnings Per Share	$-8.65	$-92.00	$-1,540.00	$-1,220.00	$-,760.00	$-1,122.60	$-1,820.00	$-2,040.00	$-2,661.40	$-2,880.00
Div.	Dividends	N/A	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
PR %	Payout Ratio %	0	0	0	0	0	0	0	0	0	0
Sha.	Shares	N/AM	0.93M	0.07M	0.04M	0.03M	0.02M	0.02M	0.01M	0.01M	0.01M
OCF	Operating Cash Flow	N/A	$0.00M	$0.00M	$0.00M	$0.00M	$0.00M	$-24.56M	$-23.30M	$-25.48M	$0.00M
FCF	Free Cash Flow	N/A	$0.00M	$0.00M	$0.00M	$0.00M	$-16.19M	$-25.42M	$-24.62M	$-25.77M	$0.00M
FCFS	Free Cash Flow Per Share	$-6.98	$-83.48	$-26.98	$-0.56	$-0.32	$-0.50	$-0.84	$-0.83	$-1.17	$-1.28

Agile Therapeutics financials at a glance

Financials

Discover